Martine van Vugt

Directeur/Membre du Conseil chez SCANDION ONCOLOGY A/S

71 ans

Health Technology

Consumer Services

Relations actives

Nom	Sexe	Age	Sociétés liées	Collaboration
Johnny Stilou	M	57	SCANDION ONCOLOGY A/S	3 ans
Jan van de Winkel	M	63	GENMAB A/S	25 ans
Deirdre Connelly	F	63	GENMAB A/S	7 ans
Martin Møller	M	49	SCANDION ONCOLOGY A/S	3 ans
Jørgen Vilhelm Bardenfleth	M	69	SCANDION ONCOLOGY A/S	6 ans
Pernille Erenbjerg	F	57	GENMAB A/S	9 ans
Jan Stenvang	M	-	SCANDION ONCOLOGY A/S	7 ans
Anthony Pagano	M	46	GENMAB A/S	17 ans
Susan Coles	F	58	TME PHARMA N.V.	3 ans
Paolo Augusto Paoletti	M	73	GENMAB A/S	9 ans
Marisol Peron	F	-	GENMAB A/S	5 ans
Keld Flintholm Jørgensen	M	53	SCANDION ONCOLOGY A/S	2 ans
Elizabeth O'Farrell	F	59	GENMAB A/S	2 ans
Alejandra Maria Mørk	M	63	SCANDION ONCOLOGY A/S	2 ans
Rolf K. Hoffmann	M	64	GENMAB A/S	8 ans
Maarten Ligtenberg	M	-	Immagene BV Immagene BV Pharmaceuticals: MajorHealth Technology Immagene BV is a private biotech company based in the Netherlands that is dedicated to developing next-generation precision immuno-oncology treatments. Immagene is committed to transforming cancer treatment and has a focus on precision medicine. The Dutch company was founded on world-leading research from the Netherlands Cancer Institute and drug R & D expertise from industry veterans. The company was founded by Maarten Ligtenberg, Christian Blank, and Daniel Peeper, with Maarten Ligtenberg serving as the CEO since incorporation.	-
Tahamtan Ahmadi	M	51	GENMAB A/S	7 ans
Martin Schultz	M	49	GENMAB A/S	2 ans
Takahiro Hamatani	M	50	GENMAB A/S	2 ans
Nicky Vogels	F	-	Immagene BV Immagene BV Pharmaceuticals: MajorHealth Technology Immagene BV is a private biotech company based in the Netherlands that is dedicated to developing next-generation precision immuno-oncology treatments. Immagene is committed to transforming cancer treatment and has a focus on precision medicine. The Dutch company was founded on world-leading research from the Netherlands Cancer Institute and drug R & D expertise from industry veterans. The company was founded by Maarten Ligtenberg, Christian Blank, and Daniel Peeper, with Maarten Ligtenberg serving as the CEO since incorporation.	-
Christopher Cozic	M	46	GENMAB A/S	-
Anthony Mancini	M	53	GENMAB A/S	4 ans
Allard Kaptein	M	-	Immagene BV Immagene BV Pharmaceuticals: MajorHealth Technology Immagene BV is a private biotech company based in the Netherlands that is dedicated to developing next-generation precision immuno-oncology treatments. Immagene is committed to transforming cancer treatment and has a focus on precision medicine. The Dutch company was founded on world-leading research from the Netherlands Cancer Institute and drug R & D expertise from industry veterans. The company was founded by Maarten Ligtenberg, Christian Blank, and Daniel Peeper, with Maarten Ligtenberg serving as the CEO since incorporation.	-
Mijke Zachariasse	M	51	GENMAB A/S	5 ans
Morten Nissen	M	-	SCANDION ONCOLOGY A/S	-
Judith Klimovsky	M	67	GENMAB A/S	7 ans
Shobhit Dhawan	M	-	Immagene BV Immagene BV Pharmaceuticals: MajorHealth Technology Immagene BV is a private biotech company based in the Netherlands that is dedicated to developing next-generation precision immuno-oncology treatments. Immagene is committed to transforming cancer treatment and has a focus on precision medicine. The Dutch company was founded on world-leading research from the Netherlands Cancer Institute and drug R & D expertise from industry veterans. The company was founded by Maarten Ligtenberg, Christian Blank, and Daniel Peeper, with Maarten Ligtenberg serving as the CEO since incorporation.	-
Birgitte Stephensen	F	63	GENMAB A/S	22 ans
Andrew Carlsen	M	-	GENMAB A/S	5 ans
François Martelet	M	64	SCANDION ONCOLOGY A/S	1 ans
Anders Gersel Pedersen	M	73	GENMAB A/S	21 ans
Lars Damstrup	M	-	SCANDION ONCOLOGY A/S	1 ans

Graphique Relationnel

Relation dans plusieurs entreprises

Anciennes relations

Nom	Sexe	Age	Sociétés liées	Collaboration
Daniel John Bruno	M	45	GENMAB A/S	5 ans
Bo Rode Hansen	M	-	SCANDION ONCOLOGY A/S	2 ans
Michael Blair Widmer	M	76	GENMAB A/S	11 ans
Mats Gunnar Pettersson	M	78	GENMAB A/S	7 ans
Burt Malkiel	M	90	GENMAB A/S	11 ans
Bo Kruse	M	52	GENMAB A/S	8 ans
Michael K. Bauer	M	60	GENMAB A/S	14 ans
Peter Michael Vestlev	M	-	SCANDION ONCOLOGY A/S	-
Helle Husted	F	-	GENMAB A/S	-
Lisa N. Drakeman	M	70	GENMAB A/S	11 ans
Nedjad Losic	M	55	GENMAB A/S	-
Tom Vink	M	61	GENMAB A/S	-
Rachel Curtis Gravesen	F	55	GENMAB A/S	8 ans
Hans Henrik Munch-Jensen	M	64	GENMAB A/S	8 ans
Maj Hedtjärn	M	-	SCANDION ONCOLOGY A/S	1 ans
Joseph deBethizy	M	74	TME PHARMA N.V.	7 ans
Nils Aage Brünner	M	72	SCANDION ONCOLOGY A/S	-
Antonius Theodorus M Wilderbeek	M	74	GENMAB A/S	2 ans
Jonathan Peacock	M	66	GENMAB A/S	1 ans
Karsten Havkrog Pedersen	M	74	GENMAB A/S	11 ans
Christina Hahner	F	-	GENMAB A/S	-
Bertram Köhler	M	53	TME PHARMA N.V.	5 ans
Richard Gordon Hibbert	M	44	GENMAB A/S	3 ans
Irwin Lerner	M	93	GENMAB A/S	-
Steen Lisby	M	60	GENMAB A/S	9 ans
Joris Wilms	M	50	GENMAB A/S	2 ans
Christian Vinding Thomsen	M	-	SCANDION ONCOLOGY A/S	5 ans
Nicklas Lindland Roest	F	39	SCANDION ONCOLOGY A/S	-
Patrick van Berkel	M	55	GENMAB A/S	9 ans
Rima Bawarsh Nassar	M	70	GENMAB A/S	-
Suba Krishnan	M	59	GENMAB A/S	1 ans
Eva Ehrnrooth	M	57	GENMAB A/S	2 ans
Peter Storm Kristensen	M	49	GENMAB A/S	-
Barry Littlejohns	M	58	GENMAB A/S	-
Jorgen Petersen	M	-	GENMAB A/S	-
Alfredo Zurlo	M	-	SCANDION ONCOLOGY A/S	-
Rikke Glahn Ren	F	-	GENMAB A/S	-
Hanne Damgaard Jensen	F	-	GENMAB A/S	8 ans
Paul W. H. I. Parren	M	60	GENMAB A/S	16 ans
Annarie Lyles	M	63	GENMAB A/S	-
David Andrew Eatwell	M	63	GENMAB A/S	12 ans
Joseph Fred Yospe	M	66	GENMAB A/S	2 ans
Michael Wolff Jensen	M	53	GENMAB A/S	3 ans
Claus Juan Møller-San Pedro	M	62	GENMAB A/S	9 ans
Ernst H. Schweizer	M	-	GENMAB A/S	-
Bryan Jennings	M	-	TME PHARMA N.V.	1 ans
Gregory Weaver	M	68	TME PHARMA N.V.	1 ans
Mads Aaboe Jensen	M	-	SCANDION ONCOLOGY A/S	-

Statistiques

Pays	Relations	% du total
Danemark	71	88,75%
Allemagne	5	6,25%
Pays-Bas	4	5,00%

Age des relations

Actives

Passées

Homme

Femme

Administrateurs

Exécutifs

Provenance des relations

Bourse
Insiders
Martine van Vugt
Réseau Personnel